4 completed, 2 unknown. 2 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Antibiotic Toxicity: new trials by email Literature Review of Antibiotic Toxicity trials Research Report on Antibiotic Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis No intervention (observational study) - Antibiotic Toxicity, Liver Cirrhosis | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 20 | 2023-07-10 | 2026-01-08 | |
| A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency Polymyxin B - Antibiotic Toxicity | Phase 1 | Completed | TTY Biopharm | 22 | 2022-07-26 | 2023-04-27 |
| Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis Dosage of serum and peritoneal of the betalactam used for antibiotic treatment - Peritonitis, Appendicitis | Not applicable | Unknown | Central Hospital, Nancy, France | 41 | 2022-03-31 | 2022-04-04 |
| Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) Levofloxacin - Urosepsis, Bladder Cancer | Not applicable | Completed | Jessa Hospital | 1350 | 2018-09-17 | 2020-02-24 |
| Target Attainment of TDM-guided Infusion of Piperacillin/Tazobactam and Cefepim in Critically Ill Patients dosage of concentration of piperacillin and cefepim - Critical Illness, Antibiotic Toxicity | Completed | Central Hospital, Nancy, France | 99 | 2018-05-02 | 2020-08-28 | |
| First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition Ceftriaxone, Benzyl penicillin, Metronidazole - Malnutrition Severe, Antibiotic Resistance | Phase 3 | Unknown | University of Oxford | 2000 | 2017-09-04 | 2020-05-19 |
Appendicitis (1) · Bacterial Infections (1) · Critical Illness (1) · Liver Cirrhosis (1) · Peritonitis (1) · Prostatic Hyperplasia (1) · Renal Insufficiency (1) · Sepsis (1) · Shock, Septic (1) · Urinary Bladder Neoplasms (1)
Infections (3) · Digestive System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Bacterial Infections and Mycoses (1) · Cecal Diseases (1) · Disease Attributes (1) · Fibrosis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1)
Cefepime (1) · Ceftriaxone (1) · Gentamicins (1) · Levofloxacin (1) · Metronidazole (1) · Observation (1) · Penicillin G (1) · Polymyxin B (1)
Central Hospital, Nancy, France (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Jessa Hospital (1) · TTY Biopharm (1) · University of Oxford (1)
Belgium (1) · France (1) · Kenya (1) · Netherlands (1) · Taiwan (1) · Uganda (1)
James A Berkely, FRCPCH (1) · Koenraad van Renterghem, PhD (1)